🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jefferies Group’s EW Holdings & Trades

First Buy
Q1 2023
Duration Held
15 Quarters
Largest Add
Q3 2026
+257,180 Shares
Current Position
296,800 Shares
$25.62 M Value

Jefferies Group's EW Position Overview

Jefferies Group (via Jefferies Financial Group Inc.) currently holds 296,800 shares of Edwards Lifesciences Corporation (EW) worth $25.62 M, representing 0.19% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 15 quarters.

Based on 13F filings, Jefferies Group has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 257,180 shares. Largest reduction occurred in Q2 2024, reducing 69,087 shares.

Analysis based on 13F filings available since 2013 Q2

Jefferies Group's Edwards Lifesciences Corporation (EW) Holding Value Over Time

Track share changes against reported price movement

Quarterly Edwards Lifesciences Corporation (EW) Trades by Jefferies Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +257,180 Add 649.12% 296,800 $86.32
Q2 2026 -4,731 Reduce 10.67% 39,620 $90.46
Q1 2026 +18,762 Add 73.32% 44,351 $80.08
Q4 2025 -26,911 Reduce 51.26% 25,589 $85.25
Q3 2025 +52,500 New Buy 52,500 $77.77
Q2 2025 -41,969 Sold Out 0 $0.00
Q1 2025 -8,769 Reduce 17.28% 41,969 $72.48
Q4 2024 -40,964 Reduce 44.67% 50,738 $74.03
Q3 2024 +51,202 Add 126.42% 91,702 $65.99
Q2 2024 -69,087 Reduce 63.04% 40,500 $92.37
Q1 2024 -68,726 Reduce 38.54% 109,587 $95.56
Q4 2023 +171,304 Add 2444.06% 178,313 $76.25
Q3 2023 +4,790 Add 215.86% 7,009 $69.28
Q2 2023 -44,481 Reduce 95.25% 2,219 $94.33
Q1 2023 +46,700 New Buy 46,700 $82.73

Jefferies Group's Edwards Lifesciences Corporation Investment FAQs

Jefferies Group first purchased Edwards Lifesciences Corporation (EW) in Q1 2023, acquiring 46,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jefferies Group has held Edwards Lifesciences Corporation (EW) for 15 quarters since Q1 2023.

Jefferies Group's largest addition to Edwards Lifesciences Corporation (EW) was in Q3 2026, adding 296,800 shares worth $25.62 M.

According to the latest 13F filing for Q3 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 296,800 shares of Edwards Lifesciences Corporation (EW), valued at approximately $25.62 M.

As of the Q3 2026 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.19% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.

Jefferies Group's peak holding in Edwards Lifesciences Corporation (EW) was 296,800 shares, as reported at the end of Q3 2026.